Monopar Therapeutics Inc. (MNPR)

NASDAQ: MNPR · Real-Time Price · USD

35.86

+2.35 (7.01%)

At close: Aug 14, 2025, 4:00 PM

36.94

+1.08 (3.01%)

After-hours: Aug 14, 2025, 5:37 PM EDT

Monopar Therapeutics Market Cap

Monopar Therapeutics has a market cap or net worth of $221.25 million as of August 14, 2025. Its market cap has increased by 1,621.92% in one year.

Market Cap

221.25M

Enterprise Value

161.89M

1-Year Change

1,621.92%

Ranking

#3742

Market Cap Chart

Since December 19, 2019, Monopar Therapeutics's market cap has decreased from $276.16M to $221.25M, a decrease of -19.88%. That is a compound annual growth rate of -3.84%.

Market Cap History

Date	Market Cap	% Change
Aug 13, 2025	204.92M	52.74%
Dec 31, 2024	134.17M	2,552.79%
Dec 29, 2023	5.06M	-83.48%
Dec 30, 2022	30.62M	-24.23%
Dec 31, 2021	40.42M	-42.33%
Dec 31, 2020	70.09M	-59.48%
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	592.95B
Johnson & Johnson	420.06B
AbbVie	355.91B
UnitedHealth Group	246.17B
AstraZeneca	240.81B
Novartis AG	234.72B
Novo Nordisk	227.37B
Abbott Laboratories	225.22B

Market Cap Rankings